Reducing injection burden has long been a priority in diabetes care. Now, a weekly, fixed-dose combination of basal insulin and a GLP-1 receptor agonist is one step closer to approval in Europe.

Medicines such as semaglutide, which are sold under brand names like Wegovy and Ozempic, help people lose weight by reducing appetite and slowing digestion. These drugs work by copying the action of a ...

Researchers are developing a two-part therapy for type 1 diabetes: lab-made insulin-producing cells paired with ...

Semaglutide (Ozempic®, Wegovy®, Rybelsus®) comes in both injection and oral form. But beyond how you take it, what’s the difference? And which form is more effective for weight loss? Semaglutide ...

With Ozempic now approved in India for type 2 diabetes management, the conversation around glucagon-like peptide-1 (GLP-1) therapies has gained momentum. According to medical experts, the launch of ...

You might have heard about medications like Ozempic®, Mounjaro®, and metformin for weight loss. But these drugs are actually diabetes medications that are sometimes prescribed off-label for weight ...